3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
50
Prostatic Neoplasms
29
Neoplasms
29
Head and Neck Neoplasms
15
Lung Neoplasms
14
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Urinary Bladder Neoplasms
6
Sarcoma
6
Oropharyngeal Neoplasms
6
Hematologic Neoplasms
6
Gastrointestinal Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Rectal Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Motor Activity
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Depression
5
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycystic Ovary Syndrome
4
Melanoma
4
Lymphoma
4
Anxiety Disorders
4
Stomach Neoplasms
3
Pain
3
Osteosarcoma
3
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Temozolomide
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Surveys and Questionnaires
×
1 year
×
Clear all
No trials found.